Your session is about to expire
← Back to Search
Procedure
Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis
N/A
Waitlist Available
Led By R Rox Anderson, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at multiple time points, last at 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial investigates using a special image-guided laser to treat people with excessive sweating by targeting and destroying their sweat glands.
Eligible Conditions
- Excessive Sweating
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at multiple time points, last at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at multiple time points, last at 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Measurement of changes in sweat production using gravimetric method
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Treated sideExperimental Treatment1 Intervention
Two regions are designated on the upper back. Randomized to treatment and control sides.
Treatment side receives laser treatment of the sweat glands.
Group II: Untreated sideActive Control1 Intervention
Two regions are designated on the upper back. Randomized to treatment and control sides.
Control side is untreated.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Laser treatment
2022
Completed Phase 3
~580
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
3,026 Previous Clinical Trials
13,413,784 Total Patients Enrolled
ScitonIndustry Sponsor
19 Previous Clinical Trials
1,347 Total Patients Enrolled
R Rox Anderson, MDPrincipal InvestigatorMassachusetts General Hospital